Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial
Academic Article
Publication Date:
2015
abstract:
Background Our previous study in patients with cerebellar ataxias of different causes showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in patients with spinocerebellar ataxia or Friedreich's ataxia in a 1-year trial.
Iris type:
01.01 Articolo in rivista
Keywords:
riluzolo; atassia spinocerebellare; atassia di Friedreich
List of contributors:
Frontali, Marina
Published in: